블랙 다이아몬드 테라퓨틱스(Black Diamond Therapeutics)
US ˙ NasdaqGS ˙ US09203E1055

SecurityBDTX / Black Diamond Therapeutics, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership7,229 shares
Latest Disclosed Value $ 17,927
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 90.24% decrease in ownership of BDTX / Black Diamond Therapeutics, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 7,229 shares of Black Diamond Therapeutics, Inc. (US:BDTX) valued at $17,928 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 74,061 shares of Black Diamond Therapeutics, Inc.. This represents a change in shares of -90.24% during the quarter. The current value of the position is $14,241 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Black Diamond Therapeutics EC US09203E1055 7,229 -66,832 -90.24 18 -85.09 0.0004
2025-05-28 2025-03-31 NP Black Diamond Therapeutics EC US09203E1055 74,061 0 0.00 115 -27.85 0.0028
2025-02-25 2024-12-31 NP Black Diamond Therapeutics EC US09203E1055 74,061 0 0.00 158 -50.93 0.0035
2024-11-26 2024-09-30 NP Black Diamond Therapeutics EC US09203E1055 74,061 74,061 322 0.0061
2022-08-25 2022-06-30 NP Black Diamond Therapeutics EC US09203E1055 0 -46,156 -100.00 0 -100.00
2022-05-26 2022-03-31 NP Black Diamond Therapeutics EC US09203E1055 46,156 0 0.00 128 -48.37 0.0030
2022-02-25 2021-12-31 NP Black Diamond Therapeutics EC US09203E1055 46,156 0 0.00 246 -36.92 0.0053
2021-11-24 2021-09-30 NP Black Diamond Therapeutics EC US09203E1055 46,156 0 0.00 390 -30.60 0.0086
2021-08-26 2021-06-30 NP Black Diamond Therapeutics EC US09203E1055 46,156 18,624 67.64 563 -15.74 0.0121
2021-05-27 2021-03-31 NP Black Diamond Therapeutics EC US09203E1055 27,532 -1,747 -5.97 668 -28.89 0.0151
2021-02-25 2020-12-31 NP Black Diamond Therapeutics EC US09203E1055 29,279 0 0.00 938 5.99 0.0240
2020-11-25 2020-09-30 NP Black Diamond Therapeutics EC US09203E1055 29,279 9,035 44.63 885 3.75 0.0284
2020-08-27 2020-06-30 NP Black Diamond Therapeutics EC US09203E1055 20,244 830 4.28 853 76.24 0.0279
2020-06-01 2020-03-31 NP Black Diamond Therapeutics EC US09203E1055 19,414 19,414 484 0.0198
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.